Evelina Pogoriler

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

J. Wolchok, R. Halaban, J. Allison, 2011, Proceedings of the National Academy of Sciences.

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

J. Wolchok, J. Allison, N. Segal, 2008, Proceedings of the National Academy of Sciences.

Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.

J. Wolchok, J. Allison, M. Callahan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: Correlation with clinical outcomes.

J. Wolchok, A. Yang, Jianda Yuan, 2010 .